Correlation Between Atreca Inc and Allovir

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Atreca Inc and Allovir at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atreca Inc and Allovir into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Atreca Inc Cl and Allovir, you can compare the effects of market volatilities on Atreca Inc and Allovir and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atreca Inc with a short position of Allovir. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atreca Inc and Allovir.

Diversification Opportunities for Atreca Inc and Allovir

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between Atreca and Allovir is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Atreca Inc Cl and Allovir in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allovir and Atreca Inc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atreca Inc Cl are associated (or correlated) with Allovir. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allovir has no effect on the direction of Atreca Inc i.e., Atreca Inc and Allovir go up and down completely randomly.

Pair Corralation between Atreca Inc and Allovir

Given the investment horizon of 90 days Atreca Inc Cl is expected to under-perform the Allovir. But the stock apears to be less risky and, when comparing its historical volatility, Atreca Inc Cl is 1.1 times less risky than Allovir. The stock trades about -0.11 of its potential returns per unit of risk. The Allovir is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  765.00  in Allovir on July 4, 2022 and sell it today you would earn a total of  24.00  from holding Allovir or generate 3.14% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Atreca Inc Cl  vs.  Allovir

 Performance (%) 
       Timeline  
Atreca Inc Cl 
Atreca Performance
0 of 100
Over the last 90 days Atreca Inc Cl has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's technical and fundamental indicators remain relatively steady which may send shares a bit higher in November 2022. The new chaos may also be a sign of medium-term up-swing for the company stakeholders.

Atreca Price Channel

Allovir 
Allovir Performance
11 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Allovir are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Allovir reported solid returns over the last few months and may actually be approaching a breakup point.

Allovir Price Channel

Atreca Inc and Allovir Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Atreca Inc and Allovir

The main advantage of trading using opposite Atreca Inc and Allovir positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atreca Inc position performs unexpectedly, Allovir can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will offset losses from the drop in Allovir's long position.
Atreca Inc vs. Samsonite
Atreca Inc vs. Archer
Atreca Inc vs. Asics Corp
Atreca Inc vs. Samsonite Intl
The idea behind Atreca Inc Cl and Allovir pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Allovir vs. RLX Technology
Allovir vs. British American Tob
Allovir vs. British American Tobacco
Allovir vs. Scandinavian Tob Group
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go